3 equities research analysts have issued 1 year price objectives for Trevena's shares. View analyst ratings for Trevena or view top-rated stocks. What happens next will shock you…". ET by Tomi Kilgore Trevena started at outperform with $16 stock price target at FBR & Co. MarketBeat just released five new trading ideas, but Trevena wasn't one of them. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Securities registered pursuant to Section 12(g) of the Act: None . Trevena Inc () Stock Market info Recommendations: Buy or sell Trevena stock? P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Yes ☐ No ☒ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. View which stocks are hot on social media with MarketBeat's trending stocks report. According to analysts' consensus price target of $5.00, Trevena has a forecasted upside of 133.1% from its current price of $2.15. All rights reserved. The biopharmaceutical company reported ($0.06) earnings per share for the quarter, meeting the consensus estimate of ($0.06). Wall Street Stock Market & Finance report, prediction for the future: You'll find the Tattooed Chef Inc - Class A share forecasts, stock quote and buy / sell signals below.According to present data Tattooed Chef Inc - Class A's TTCF shares and potentially its market environment have … Shares of TRVN can be purchased through any online brokerage account. 1. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Vote “Outperform” if you believe TRVN will outperform the S&P 500 over the long term. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings. To read this article on Zacks.com click here. The official website for Trevena is www.trevena.com. This suggests a possible upside of 123.2% from the stock's current price. NASDAQ Global Select Market . Real time Trevena (TRVN) stock price quote, stock graph, news & analysis. Learn more. Anavex’s loss per share estimates have narrowed from 64 cents to 48 cents for … Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Investors in Trevena, Inc. TRVN need to pay close attention to the stock based on moves in the options market lately. Yes ☐ No ☒ Indicate by check mark if the registrant is not required to file … Currently, Trevena is a Zacks Rank #3 (Hold) stock. Clearly, options traders are pricing in a big move for Trevena shares, but what is the fundamental picture for the company? Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Based on aggregate information from My MarketBeat watchlists, some companies that other Trevena investors own include Conatus Pharmaceuticals (CNAT), Novavax (NVAX), Sorrento Therapeutics (SRNE), ADMA Biologics (ADMA), SCYNEXIS (SCYX), Matinas BioPharma (MTNB), Zosano Pharma (ZSAN), Aeterna Zentaris (AEZS), Bionano Genomics (BNGO) and Dynavax Technologies (DVAX). Trevena's management team includes the following people: Man Who Predicted March 2020 Crash Makes Bold Tech Stock Prediction. The consensus among Wall Street equities research analysts is that investors should "buy" Trevena stock. Stocks rise as US and China inflation data comes into focus. Provides Update on Commercial Launch Activities for OLINVYK™ and Announces Anticipated Pipeline Catalysts - GlobeNewswire, view top-rated stocks among Wall Street analysts, Receive Analysts' Upgrades and Downgrades Daily. Tattooed Chef Inc - Class A () Stock Market info Recommendations: Buy or sell Tattooed Chef Inc - Class A stock? Their forecasts range from $5.00 to $5.00. Trevena has received 608 “outperform” votes. Investors in Trevena, Inc. TRVN need to pay close attention to the stock based on moves in the options market lately. View all of TRVN's competitors. This group includes 892 individual stocks … 3 brokers have issued 12-month price targets for Trevena's stock. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Trevena share forecasts, stock quote and buy / sell signals below.According to present data Trevena's TRVN shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). TRVN stock was sold by a variety of institutional investors in the last quarter, including Virtu Financial LLC. Find real-time OVID - Ovid Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected. Learn more. Over the last 60 days, one analyst has increased the earnings estimates for the current quarter, while none have revised their estimates downward. Kandi Technologies Group Inc () Stock Market info Recommendations: Buy or sell Kandi Technologies Group stock? Earnings for Trevena are expected to decrease in the coming year, from ($0.22) to ($0.30) per share. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Only 5.20% of the stock of Trevena is held by insiders. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. That is because the Dec 18, 2020 $2.50 Call had some of the highest implied volatility of all equity options today. Indicate by check mark if the registrant is a well‑known seasoned issuer, as defined in Rule 405 of the Securities Act. Announces Publication Highlighting OLINVYK™ Respiratory Safety Data in High-Risk Patients in Pain & Therapy - GlobeNewswire, Trevena, Inc. Trevena, Inc. (NASDAQ:TRVN) posted its quarterly earnings results on Thursday, May, 7th. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Learn everything you need to know about successful options trading with this three-part video course. Get short term trading ideas from the MarketBeat Idea Engine. It could also mean there is an event coming up soon that may cause a big rally or a huge sell off. Yes ☐ No ☒ Indicate by check mark if the registrant i © American Consumer News, LLC dba MarketBeat® 2010-2021. Trevena employs 24 workers across the globe. CHESTERBROOK, Pa., Jan. 06, 2021 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today provided an update on the U.S. commercial launch for OLINVYK (oliceridine) injection and announced anticipated milestones for 2021. The stock was last up 35% to $87.80 when it was halted for volatility. The net effect has taken our Zacks Consensus Estimate for the current quarter from a loss of 6 cents per share to a loss of 3 cents in that period.Given the way analysts feel about Trevena right now, this huge implied volatility could mean there’s a trade developing. Trevena is headquartered at 955 Chesterbrook Boulevard Suite 110, Chesterbrook PA, 19087. UK says Myanmar killings are abhorrent, urges return to democracy, Skateboarder Nyjah Huston on going to the Olympics: 'I'm stoked', UPDATE 2-Fauci urges Americans to get any of the three COVID-19 vaccines available, UPDATE 2-Israel to vaccinate Palestinian labourers against COVID-19, Aramco seeks one-year extension on $10 billion loan: sources. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Trevena's mailing address is 955 Chesterbrook Boulevard Suite 110, Chesterbrook PA, 19087. Trevena, Inc. (Exact Name of Registrant as Specified in Its Charter) ... Common Stock, par value $0.001 per share. Exosome Diagnostics and Therapeutics Market 2021 Upcoming Developments, … Trevena, Inc. (NASDAQ:TRVN) has a beta value of 2.9 and has seen 2,726,211 shares traded in the last trading session. Trevena does not currently pay a dividend. In addition to impressive profit potential, these trades can actually reduce your risk.Click to see the trades now >>, Want the latest recommendations from Zacks Investment Research? The Nasdaq Stock Market LLC . Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. Amazon price started in 2021 at $3,256.93. Lawyers protesting against police in Tunisia allegedly attacked by officers. The NIO Inc. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. View insider buying and selling activity for Trevena or or view top insider-buying stocks. The data center construction market is expected to grow at a CAGR of 4.8% during the period 2021–2026. You can opt out at any time. Learn about financial terms, types of investments, trading strategies and more. Trevena is scheduled to release its next quarterly earnings announcement on Thursday, March 11th 2021. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. In the past three months, Trevena insiders have not sold or bought any company stock. Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. To see all exchange delays and terms of use please see disclaimer. This suggests a possible upside of 133.1% from the stock's current price. Currently there seems to be … Gun, Security Stocks Surge As Protestors Storm US Capitol January 6, 2021 | msn.com. Zacks Investment Research, Trevena, Inc. (TRVN) : Free Stock Analysis Report. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. \\-- OLINVYK significantly reduced risk of vomiting and rescue antiemetic use compared to IV morphine in a retrospective analysis\\--CHESTERBROOK, Pa., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today … There are currently 3 buy ratings for the stock. Announces Publication Highlighting OLINVYK™ Respiratory Safety Data in High-Risk Patients in Pain & Therapy, Trevena's Catalyst-Filled Q1 - Seeking Alpha, Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences - Yahoo Finance, Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences, Trevena, Inc. Next reporting date: May 4, 2021: EPS forecast (this quarter) $0.70: Annual revenue (last year) $2.9B: Annual profit (last year) $319.5M: Net profit margin Trevena has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. On corrections up, there will be some resistance from the lines at $53.95 and $57.60. On average, they anticipate Trevena's share price to reach $5.00 in the next year. Story continues. Often times, options traders look for options with high levels of implied volatility to sell premium. Currently, Trevena is a Zacks Rank #3 (Hold) in the Medical – Biomedical and Genetics industry that ranks in Bottom 23% of our Zacks Industry Rank. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Trevena's stock is owned by a number of institutional and retail investors. Trevena has received a consensus rating of Buy. “The sudden, sharp surge in GameStop’s share price and valuation likely has been fueled by a short squeeze, given the high short interest, and, to a lesser degree, speculation by retail investors on forecasts for the new gaming cycle and the involvement of activist RC Ventures,” Telsey analyst Joseph Feldman said in the note on … See what's happening in the market right now with MarketBeat's real-time news feed. View analysts' price targets for Trevena or view top-rated stocks among Wall Street analysts. Former Hummer plant that is EV kitted and ready for production in Indiana. Investors need to pay close attention to Trevena (TRVN) stock based on the movements in the options market lately. Man Gets Into a Tesla… What Happens Next Will Shock Everyone (Video), "Hi, I'm Jeff Brown… I'm about to get in this Tesla and drive up to a location just a few miles from here to show you Elon Musk's next big project… Trevena, Inc. was founded in 2007 and is headquartered in Chesterbrook, Pennsylvania. The Indiana Factory . (Add your “outperform” vote. Export data to Excel for your own analysis. Capricor Therapeutics Stock Forecast, Price & News $6.22-0.43 (-6.47 %) (As of 02/25/2021 11:50 AM ET) ... Duchenne Muscular Dystrophy Drug Market Latest Report: Top Company Profiles, CAGR, Production And Sales Estimations and Forecast 2025 December 21, 2020 | marketwatch.com. The biopharmaceutical company can be reached via phone at 610-354-8840 or via email at [email protected]. Do Not Sell My Information. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Implied volatility shows how much movement the market is expecting in the future. 2. (Add your “underperform” vote.). Two folding iPhone handsets have now allegedly passed durability testing … Trevena, Inc. (TRVN) : Free Stock Analysis Report To read this article on Zacks.com click here. You may vote once every thirty days. Looking for new stock ideas? IV. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Kandi Technologies Group share forecasts, stock quote and buy / sell signals below.According to present data Kandi Technologies Group's KNDI shares and potentially its market environment have been in a … Trevena started at buy with $15 stock price target at Ladenburg Thalmann Feb. 2, 2017 at 7:40 a.m. Some companies that are related to Trevena include MannKind (MNKD), Cytokinetics (CYTK), Keros Therapeutics (KROS), Indivior (INVVY), BioXcel Therapeutics (BTAI), Rhythm Pharmaceuticals (RYTM), Arcturus Therapeutics (ARCT), Phathom Pharmaceuticals (PHAT), Mersana Therapeutics (MRSN), Cassava Sciences (SAVA), Omeros (OMER), Repare Therapeutics (RPTX), Constellation Pharmaceuticals (CNST), Northwest Biotherapeutics (NWBO) and Zogenix (ZGNX). However, implied volatility is only one piece of the puzzle when putting together an options trading strategy. Investors focused on the Medical space have likely heard of Trevena, Inc. (TRVN), but is the stock performing well in comparison to the rest of its sector peers? One share of TRVN stock can currently be purchased for approximately $2.15. SoFi Merging With Palihapitiya-Backed IPOE SPAC January 7, 2021 | msn.com. A break-up above any of these levels will issue … Trevena, Inc. is a member of the Medical sector. 4. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Receive a free world-class investing education from MarketBeat. You can see the complete list of today’s Zacks #1 Rank stocks here. Trevena's stock was trading at $0.6984 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Another MASSIVE way that ELMS will save a boatload of cash, and speed up the production of their van, is through the former Hummer plant that … Don’t stop supermarkets selling … Sign-up to receive the latest news and ratings for TRVN and its competitors with MarketBeat's FREE daily newsletter. Click to get this free report Trevena, Inc. (TRVN) : Free Stock Analysis Report To read this article on Zacks.com click here. View Trevena's earnings history. A few better-ranked stocks in the biotech sector are Anavex Life Sciences Corp. AVXL, Guardant Health Inc. GH and Oncolytics Biotech Inc. ONCY, all sporting a Zacks Rank #1 (Strong Buy). Today, Amazon traded at $3,194.50, so the price decreased by -2% from the … The TRVN stock price is -41.54% off its 52-week high price of $3.68 and 82.31% above the 52-week low of $0.46. Trevena has a market capitalization of $336.83 million and generates $30,000.00 in revenue each year. Top institutional shareholders include BlackRock Inc. (1.68%), Renaissance Technologies LLC (0.69%), Northern Trust Corp (0.18%), ExodusPoint Capital Management LP (0.16%), Squarepoint Ops LLC (0.15%) and Wells Fargo & Company MN (0.12%). Securities registered pursuant to Section 12(g) of the Act: None . Wall Street analysts have given Trevena a "Buy" rating, but there may be better short-term opportunities in the market. Indicate by check mark if the registrant is a well‑known seasoned issuer, as defined in Rule 405 of the Securities Act. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Li Auto Inc - ADR share forecasts, stock quote and buy / sell signals below.According to present data Li Auto Inc - ADR's LI shares and potentially its market environment have been in a bullish cycle in the last 12 months (if … Trevena has received no research coverage in the past 90 days. The biopharmaceutical company earns $-24,870,000.00 in net income (profit) each year or ($0.27) on an earnings per share basis. The P/E ratio of Trevena is -9.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Only 11.62% of the stock of Trevena is held by institutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Common Stock, par value $0.001 per share . Warren Buffett famously said, 'Volatility is far from synonymous with risk.' TRENDING. The Global Antibiotics Market is expected to grow from AUD 51,099.70 Million in 2020 to AUD 69,625.84 Million by the end of 2025.Market Segmentation & Coverage:This research report categorizes the Antibiotics to forecast the revenues and analyze the trends in each of the following sub-markets:Based on Drug Class, the Antibiotics Market studied across Aminoglycosides, Carbapenem, … Trevena trades on the NASDAQ under the ticker symbol "TRVN.". Next reporting date: March 23, 2021: EPS forecast (this quarter) $2.79: Annual revenue (last year) $12.9B: Annual profit (last year) $5.3B: Net profit margin View our full suite of financial calendars and market data tables, all for free. This is a strategy many seasoned traders use because it captures decay. Duos Technologies Group Stock Forecast, Price & News $6.12-0.06 (-0.97 %) (As of 02/24/2021 12:00 AM ET) ... Forecast to 2025 January 8, 2021 | marketwatch.com. The company, currently valued at $398.76 Million, closed the last trade at $2.6 per share which meant it lost -$0.06 on the day or -2.26% during that session. Get daily stock ideas top-performing Wall Street analysts. They called the 2020 crash 45 days early. Yes ☐ No ☒ … Trevena has a P/B Ratio of 6.70. On average, they anticipate Trevena's stock price to reach $5.00 in the next twelve months. If we … View institutional ownership trends for Trevena. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. Trevena Inc Stock Price Forecast, "TRVN" Predictons for2025 MarketBeat's community ratings are surveys of what our community members think about Trevena and other stocks. Since then, TRVN shares have increased by 207.1% and is now trading at $2.1450. 3. Identify stocks that meet your criteria using seven unique stock screeners. Today, you can download 7 Best Stocks for the Next 30 Days. Trevena does not have a long track record of dividend growth. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Compare Top Brokerages Here. View which stocks have been most impacted by COVID-19. Li Auto Inc - ADR () Stock Market info Recommendations: Buy or sell Li Auto Inc - ADR stock?